Market Growth & Development
Show
- Market Growth & Development
- Juvenescence: from strength to strength in R&D and investment firepower
- Greg Bailey talks about the latest news from Juvenescence regarding transformative scientific opportunities, immuno-resilience, modifying aging and funding.
- 255 0
- Industry News
- BioMarin’s Gene Therapy Valrox Gets Rejected Amid Durability Concerns
- “We remain committed to the hemophilia community and to leading the way to the first ever gene therapy in hemophilia A,”
- 1025 0
- Genetic Research
- Ancestry Relaunching Genomic Health Services
- According to the company, the new offering promises to be more accurate and to provide more data by reading the portions of the genome typically left out
- 1703 0
- Innovation
- Eargo Raises Millions For Its Invisible Direct To Consumer Hearing Aid
- Eargo has recently secured millions in funding to help take advantage of the demand and expand its commercial effort for the company’s virtually invisible aids
- 1515 0
-
- Market Growth & Development
- Juvenescence: from strength to strength in R&D and investment firepower
- Greg Bailey talks about the latest news from Juvenescence regarding transformative scientific opportunities, immuno-resilience, modifying aging and funding.
- 255 0
-
- Industry News
- BioMarin’s Gene Therapy Valrox Gets Rejected Amid Durability Concerns
- “We remain committed to the hemophilia community and to leading the way to the first ever gene therapy in hemophilia A,”
- 1025 0
-
- Genetic Research
- Ancestry Relaunching Genomic Health Services
- According to the company, the new offering promises to be more accurate and to provide more data by reading the portions of the genome typically left out
- 1703 0
-
- Innovation
- Eargo Raises Millions For Its Invisible Direct To Consumer Hearing Aid
- Eargo has recently secured millions in funding to help take advantage of the demand and expand its commercial effort for the company’s virtually invisible aids
- 1515 0
Load More
